VNTN yields 2000000.00% · PFE yields 6.13%● Live data
📍 VNTN pulled ahead of the other in Year 1
Combined, VNTN + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VNTN + PFE for your $10,000?
VentureNet Capital Group, Inc. provides capital and media marketing services to public companies. It offers custom-tailored and structured products, such as PIPE financing, stock loans, equity lines of credit, and asset based financing, as well as purchases aged debt from public companies. The company's media marketing services include arrangement of investor meetings, lunches/dinners; preparation and distributions of Company reports; positioning of company for review/analysis by the sell-side, buy-side and individual investor audience; and featuring company to two exclusive, high net-worth individual investor groups, as well as conducts audio-taped CEO Webcast/audio press releases, radio interviews on the wall street news hour, and other financial radio programs. Its media marketing services also arrange for company to be included in financial newsletters and publications sent to brokers, investors, and investment bankers monthly, as well as features company on financial Websites. In addition, the company offers reverse mergers services, which consist of preparation of S-1 registration statements and form 10 filings; and handling of legal work, filings, market makers to file form 211, access to capital, and institutional and retail support for stocks. VentureNet Capital Group, Inc. was incorporated in 1989 and is based in Reno, Nevada.
Full VNTN Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.